Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi Chemical Group Corporation.
The volume of the global secondaries market grew more than 44% last year compared to 2023, reaching over $153bn, new research from Setter Capital shows.
Private markets investment major Hamilton Lane has hit a $615m final close for its hybrid Venture Access Fund, which will target both primary and secondary deals in the segment.
Bain Capital has paid $287m for a 51% stake in plastic processing equipment and services specialist Milacron, with the remainder held by current owner Hillenbrand.
Newly-launched private equity investor Northcote Equity has taken just 16 weeks to reach a £160m hard cap final close for its debut fund - turning away almost as much again thanks to heavy LP demand.
The $274bn-managing US pension major the New York State Common Retirement Fund has unveiled another $1.5bn of alternative asset fund commitments, with Summit Partners and B Capital picking up the biggest pledges.